scholarly journals Navigational Balloon Sinuplasty

2012 ◽  
Vol 147 (2_suppl) ◽  
pp. P113-P113
Author(s):  
Yi H. Kao ◽  
John F. Pallanch
Keyword(s):  
2021 ◽  
pp. 014556132098603
Author(s):  
Anni Koskinen ◽  
Marie Lundberg ◽  
Markus Lilja ◽  
Jyri Myller ◽  
Matti Penttilä ◽  
...  

Objectives: The aim of this controlled follow-up study was to compare the need for revision surgery, long-term efficacy, and satisfaction in chronic rhinosinusitis patients who had undergone maxillary sinus operation with either balloon sinuplasty or traditional endoscopic sinus surgery (ESS) technique. Methods: Thirty-nine ESS patients and 36 balloon patients of our previously described cohort, who had been primarily operated in 2008 to 2010, were contacted by phone. Symptoms, satisfaction, and need for revision surgery were asked. In addition, we collected data of patients who had undergone primary maxillary sinus balloon sinuplasty in the Helsinki University Hospital during the years 2005 to 2019. As a control group, we collected data of patients who had undergone primary maxillary sinus ESS at 3 Finnish University Hospitals, and 1 Central Hospital in years 2005, 2008, and 2011. Results: Altogether, 77 balloon patients and 82 ESS patients were included. The mean follow-up time was 5.3 years in balloon group and 9.8 years in ESS group. Revision surgery was performed on 17 balloon patients and 6 ESS patients. In the survival analysis, the balloon sinuplasty associated significantly with a higher risk of revision surgery compared to ESS. According to the phone interviews, 82% of ESS patients and 75% of balloon patients were very satisfied with the primary operation. Conclusion: Although the patient groups expressed equal satisfaction and change in symptoms after the operations, the need for revision surgery was higher after balloon sinuplasty than after ESS. This should be emphasized when counselling patients regarding surgical options.


2006 ◽  
Vol 135 (2_suppl) ◽  
pp. P151-P151 ◽  
Author(s):  
Rhoda Wynn ◽  
Winston C. Vaughan

2010 ◽  
Vol 62 (3) ◽  
pp. 225-228 ◽  
Author(s):  
Zahoor Ahmad
Keyword(s):  

2019 ◽  
Vol 162 (1) ◽  
pp. 137-141 ◽  
Author(s):  
Kevin Hur ◽  
Marshall Ge ◽  
Jeehong Kim ◽  
Elisabeth H. Ference

Objective Balloon sinuplasty utilization has increased significantly since its introduction over a decade ago. However, the most common associated complications are still unknown. The objective of this study was to analyze adverse events related to balloon sinuplasty. Study Design Retrospective cross-sectional analysis. Setting Food and Drug Administration’s MAUDE database (Manufacturer and User Facility Device Experience; 2008-2018). Subjects and Methods The MAUDE database was searched for all reports on adverse events involving balloon sinuplasty devices from the 3 leading manufacturers: Acclarent, Entellus, and Medtronic. Reported events were reviewed and categorized. Results During the study period, there were 211 adverse events from 208 reports divided into the following categories: patient related (n = 102, 48.3%), device related (n = 101, 47.9%), and packaging related (n = 8, 3.8%). Four periprocedural deaths were reported but were not clearly associated with technical complications. The most common device-related complications were guide catheter malfunction (39.6%), balloon malfunction (38.6%), and imprecise navigation (17.8%). The most common patient-related complications were cerebrospinal fluid leak (36.3%), eye swelling (29.4%), and epistaxis (11.8%). A lateral canthotomy was performed in 30.0% of eye-swelling complications. Sixty percent of eye complications occurred during balloon dilation of the maxillary sinus. The years 2014 (n = 48) and 2012 (n = 32) had the highest number of adverse events reported as compared with all other years. Conclusion The most common adverse events associated with balloon sinuplasty include balloon malfunction, guide catheter malfunction, cerebrospinal fluid leak, and significant eye swelling. Health care providers should discuss these possible complications when consenting patients for balloon sinuplasty.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Ki-Il Lee ◽  
Joong Su Park ◽  
Seon-Min Lee ◽  
Seung Min In

2006 ◽  
Vol 85 (11) ◽  
pp. 698-700 ◽  
Author(s):  
Dewey A. Christmas ◽  
Joseph P. Mirante ◽  
Eiji Yanagisawa

2013 ◽  
Vol 2013 (jan28 1) ◽  
pp. bcr2012007879-bcr2012007879 ◽  
Author(s):  
N. Hughes ◽  
J. Bewick ◽  
R. Van Der Most ◽  
M. O'Connell

2021 ◽  
Vol 42 (1) ◽  
pp. 102825
Author(s):  
Afonso Castro ◽  
Miguel Furtado ◽  
Ângela Rego ◽  
Daniela Serras ◽  
Marisol Plácido ◽  
...  

2015 ◽  
Vol 22 (2) ◽  
pp. 103
Author(s):  
Jung Min Ahn ◽  
Nayeon Choi ◽  
Hyun-Jin Cho ◽  
Hun-Jong Dhong

2019 ◽  
Vol 161 (4) ◽  
pp. 683-687 ◽  
Author(s):  
Gerard Thong ◽  
Natasha D. Dombrowski ◽  
Kosuke Kawai ◽  
Michael J. Cunningham ◽  
Eelam A. Adil

Objective Balloon sinuplasty (BS) is a surgical management option in the treatment of chronic rhinosinusitis. The purpose of this study was to examine BS utilization among children with a national database. Study Design Retrospective review. Setting National pediatric database. Subjects and Methods All cases of children aged ≤18 years who underwent BS or traditional endoscopic sinus surgery (ESS) 5 years before and after the introduction of BS billing codes were studied with the Pediatric Health Information System database. We evaluated overall trends, demographics, performing physicians, readmissions, and cost data. Results A total of 14,079 patients met inclusion criteria: 13,555 underwent traditional ESS and 524 had a BS procedure. There was no significant increase in BS rates between 2011 and 2016. BS was more commonly performed among younger children than ESS (median age [interquartile range], 6 years [4-10] vs 9 years [6-13]; P < .001). There were 23 (4.4%) readmissions within 30 days in the balloon cohort versus 474 (3.5%) in the ESS cohort. The median cost of balloon maxillary antrostomy (US $6560 [$5420-$8250]) was higher than that of traditional maxillary antrostomy (US $5630 [$4130-$7700], P < .001). Physicians who performed BS had a larger volume of ESS procedures when compared with those who did not perform BS. Conclusion Rates of BS performance in the pediatric population have not increased over time. Results showed no difference in readmission rates between BS and ESS. BS was associated with higher costs as compared with ESS. The role of BS in the pediatric chronic rhinosinusitis population remains unclear.


Sign in / Sign up

Export Citation Format

Share Document